GlassScriptPhysician profile
Kim-Chi Pham
NPI 1578523601
$6,656.40
in general payments reported to CMS, 2019-2025
18 companies · $990 in 2025
The $990 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $825 · 2021: $747 · 2022: $1,604 · 2023: $677 · 2024: $932 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,599.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,356.20 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,349.26 | 2019-2021 | |
| Alcon Vision LLC | $1,318.70 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $811.64 | 2022-2025 | Infuse, Biotrue, Xiidra |
| Coopervision INC. | $403.31 | 2019-2024 | Misight Contact Lens, Myday Contact Lens, Biofinity Contact Lens |
| Optos, INC. | $290.50 | 2020-2022 | |
| Biotissue Holdings INC. | $281.30 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $243.56 | 2023-2024 | Cequa |
| Lkc Technologies, INC. | $130.73 | 2025 | |
| Abbvie INC. | $115.42 | 2022 | |
| Harrow Eye, LLC | $97.15 | 2024-2025 | Vevye |
| Maculogix, INC. | $91.95 | 2020 | |
| Lumenis, INC | $55.19 | 2021 | |
| Dompe US, INC. | $38.67 | 2021-2024 | Oxervate |
| Oyster Point Pharma, INC. | $24.33 | 2023 | Tyrvaya |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.20 | 2022 | |
| Aerie Pharmaceuticals, INC. | $13.40 | 2021 | |
| Allergan, INC. | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim-Chi Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.